Request for Public Comment and the PATH Study

This Week in CTP - Updates from the Center for Tobacco Products On January 29, FDA published a notice in the Federal Register seeking comments, supported by scientific evidence, on what changes to smokeless tobacco warning statements would promote greater public understanding of the risks associated with the use of smokeless tobacco products. Read the full notice here and visit the website to officially submit your comments to the public docket by April 1. Did you know that FDA and NIH have initiated a joint national study designed to monitor and measure why people start using tobacco, quit using it, and start using it again after they’ve quit? The study is called the Population Assessment of Tobacco and Health, or PATH, and you can click here to learn more about its research goals.   You are subscribed to FDA Tobacco Products Email Updates. Subscriber Services: Manage Preferences | Unsubscribe | Help with this service If you have questions, please email AskCTP@fda.hhs.gov or call 1-877-CTP-1373. Food and Drug Administration | 9200 Corporate Blvd.  | Rockville, MD 20850  | www.fda.gov/tobacco This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420